Nomi Health’s Post

View organization page for Nomi Health, graphic

19,035 followers

The three most common drugs utilized by members on insurance plans self-funded by their employers: 1. Trulicy (antidiabetic) 2. Sumatriptan (antimigraine) 3. Mounjaro (antidiabetic) In our recent Trends in Spend analysis, we looked at nearly 140 million prescription claims in 2022 and 2023 to determine what’s fueling the unsustainable increase in prescription spend for employers. Here's what we discovered — and what employers can do about it.

5 Strategies for Employers to Take Charge of Prescription Spending

5 Strategies for Employers to Take Charge of Prescription Spending

Nomi Health on LinkedIn

To view or add a comment, sign in

Explore topics